Average Insider

Where insiders trade, we follow

$AMLX
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Joshua Cohen
CEO
123
Employees
$29.86
Current Price
$1.17B
Market Cap
52W Low$10.83
Current$29.8662.8% above low, 37.2% below high
52W High$41.14

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells38$7,175,258.38240,000
1 monthBuys00--All Sells
Sells38$7,175,258.38240,000
2 monthsBuys00--All Sells
Sells49$8,006,162.38270,000
3 monthsBuys00--All Sells
Sells619$10,951,124.66361,302
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 9, 2026
FRATES JAMES M
Chief Financial Officer
Sale7,700$29.39$226,292.99View Details
Nov 9, 2026
FRATES JAMES M
Chief Financial Officer
Sale12,300$30.11$370,359.15View Details
Nov 10, 2026
FRATES JAMES M
Chief Financial Officer
Sale7,200$30.97$222,982.56View Details
Nov 10, 2026
FRATES JAMES M
Chief Financial Officer
Sale12,800$30.32$388,107.52View Details
Nov 9, 2026
Klee Justin B.
Director
Sale62,517$30.11$1,882,149.31View Details
Nov 9, 2026
Klee Justin B.
Director
Sale37,483$29.39$1,101,689.09View Details
Nov 9, 2026
Cohen Joshua B
Director
Sale61,895$30.11$1,863,646.07View Details
Nov 9, 2026
Cohen Joshua B
Director
Sale38,105$29.39$1,120,031.70View Details
Oct 5, 2026
MILNE GEORGE M JR
Director
Sale30,000$27.70$830,904.00View Details
Sep 10, 2026
Bedrosian Camille L
Chief Medical Officer
Sale7,947$32.21$256,003.86View Details
Sep 10, 2026
Bedrosian Camille L
Chief Medical Officer
Sale2,081$33.09$68,864.24View Details
Sep 10, 2026
FRATES JAMES M
Chief Financial Officer
Sale1,042$33.23$34,625.87View Details
Sep 10, 2026
FRATES JAMES M
Chief Financial Officer
Sale9,768$32.27$315,194.80View Details
Sep 10, 2026
Mazzariello Gina
Chief Legal Officer
Sale11$33.34$366.74View Details
Sep 10, 2026
Mazzariello Gina
Chief Legal Officer
Sale9,525$32.46$309,139.59View Details
Sep 10, 2026
Klee Justin B.
Director
Sale1,439$33.16$47,710.33View Details
Sep 10, 2026
Klee Justin B.
Director
Sale29,025$32.13$932,552.93View Details
Sep 10, 2026
Cohen Joshua B
Director
Sale919$33.15$30,463.75View Details
Sep 10, 2026
Cohen Joshua B
Director
Sale29,545$32.16$950,040.16View Details
22 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 5, 2026
EPS
Estimated-$0.38
Actual-$0.38
Beat
Revenue
Estimated$59.43K
ActualN/A
2 more earnings records available โ€” create a free account to see 12 months of history

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.10.12